TransMedics Group Inc (TMDX)
138.42
-0.20
(-0.14%)
USD |
NASDAQ |
May 21, 16:00
136.88
-1.54
(-1.11%)
After-Hours: 20:00
TransMedics Group SG&A Expense (Quarterly): 36.16M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 36.16M |
December 31, 2023 | 34.56M |
September 30, 2023 | 30.65M |
June 30, 2023 | 29.36M |
March 31, 2023 | 24.98M |
December 31, 2022 | 21.73M |
September 30, 2022 | 16.85M |
June 30, 2022 | 17.38M |
March 31, 2022 | 13.94M |
December 31, 2021 | 12.00M |
September 30, 2021 | 10.34M |
June 30, 2021 | 9.162M |
March 31, 2021 | 6.786M |
Date | Value |
---|---|
December 31, 2020 | 6.176M |
September 30, 2020 | 5.493M |
June 30, 2020 | 5.867M |
March 31, 2020 | 6.652M |
December 31, 2019 | 6.173M |
September 30, 2019 | 6.519M |
June 30, 2019 | 6.251M |
March 31, 2019 | 4.653M |
December 31, 2018 | 4.374M |
September 30, 2018 | 2.799M |
June 30, 2018 | 2.902M |
March 31, 2018 | 2.24M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
5.493M
Minimum
Sep 2020
36.16M
Maximum
Mar 2024
15.35M
Average
11.17M
Median
SG&A Expense (Quarterly) Benchmarks
SI-BONE Inc | 37.56M |
Cutera Inc | 36.56M |
Stereotaxis Inc | 6.469M |
Electromed Inc | 8.374M |
Myomo Inc | 5.232M |